ZoomRx
ZoomRx is a strategic life sciences consulting firm and AI-powered market research company serving global pharmaceutical and biotechnology companies. It combines proprietary AI platforms (Sagan Agents, Ferma, Patient Scribe) with a 60,000+ HCP panel and 700M+ benchmark datapoints to deliver market insights across the drug lifecycle.
- Company typePrivate
- Founded2010
- HeadquartersChennai, India
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What ZoomRx does
ZoomRx is a strategic life sciences consulting firm and AI-powered market research company serving global pharmaceutical and biotechnology companies. The company delivers market insights, competitive intelligence, and commercial strategy consulting across the drug lifecycle, backed by a proprietary panel of 60,000+ healthcare professionals and 700M+ benchmark datapoints accumulated over more than 15 years of life sciences domain work. Its stated client base includes 19 of the top 20 global pharmaceutical companies and over 100 leading biopharma organizations, with named customers including Novartis, Johnson & Johnson, Sanofi, AbbVie, Roche, AstraZeneca, Amgen, Gilead, Regeneron, MSD, Biogen, BioNTech, and others.
The company's product portfolio centers on three proprietary AI platforms. Sagan Agents is a continuous intelligence platform with three modules (Strategic Insights Agents, Data Archive Intelligence, and Agentic Market Research) that uses autonomous AI agents and conversational interfaces to convert siloed client data into queryable intelligence. Patient Scribe is a voice-first conversational platform for patient chart audits that replaces click-through surveys with natural spoken dialogue, capturing physician reasoning behind treatment decisions. Ferma is an AI market intelligence platform that synthesizes drug pipelines and medical conferences in real time, including a Ferma Congress sub-product for live event coverage. Supporting services include Promotional Effectiveness Tracking (PET), Brand Tracking (ATU), Media Tracking, HCP-Patient Conversations, and commercial consulting for launch excellence and decision sciences. The underlying technology stack combines natural language processing, speech and audio processing, generative AI, autonomous agents, knowledge retrieval, predictive analytics, and process automation across text, audio, and multimodal inputs.
ZoomRx monetizes through a hybrid revenue model combining professional services and recurring subscriptions. Custom consulting engagements are priced at six figures per project, while the Sagan Agents platform is offered as an annual subscription with flexible pricing tied to the number of brands and modules deployed. A free Data Archive ingestion pilot is bundled with existing client engagements to lower switching friction. Distribution is entirely direct enterprise sales to pharmaceutical decision-makers with no third-party channel partners disclosed. The company is privately held and founder-led by Co-CEO and Co-Founder Sriram Subramanian, with no disclosed external funding rounds; it operates from a U.S. corporate entity (ZoomRx Inc.) while maintaining operational presence in Chennai, India.
ZoomRx firmographics
Firmographics- Name
- ZoomRx
- Legal name
- ZoomRx Inc.
- Website
- https://zoomrx.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- ZoomRx is a strategic life sciences consulting firm and AI-powered market research company serving global pharmaceutical and biotechnology companies. It combines proprietary AI platforms (Sagan Agents, Ferma, Patient Scribe) with a 60,000+ HCP panel and 700M+ benchmark datapoints to deliver market insights across the drug lifecycle.
- Ownership category
- akta.pro rank
Where ZoomRx is headquartered
LocationHeadquarters
- HQ city
- Chennai
- HQ country
- India
- HQ region
- Asia
Markets served
ZoomRx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Others
Revenue model
- Life Sciences Consulting: Strategic consulting engagements for pharmaceutical companies covering launch excellence, market and competitive intelligence, patient insights, and commercial strategy. Revenue generated through project-based consulting engagements with enterprise pharma clients.
- Sagan Agents Platform Subscription: AI-powered continuous intelligence platform offered as subscription with flexible pricing. Includes Data Archive pilot bundled with existing projects, and full platform pricing customized based on number of brands and modules. Delivers answers in hours instead of weeks, replacing costly one-off projects.
- Market Research Tracking Studies: Primary market research tracking studies including Promotional Effectiveness Tracking (PET), Brand Tracking (ATU), Patient Chart Audits (PCA), Media Tracking, and HCP-Patient Conversations. Continuous pharma insights form the intelligence backbone of successful biopharma commercialization.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Data Archive pilot bundled with existing engagements |
| Subscription | Annual | Full Sagan Agents platform |
| Other | Multi-year contract | Custom consulting and research engagements |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels8 records
ZoomRx product offering
Product offeringCore offering
ZoomRx delivers AI-powered market research and life sciences consulting to pharmaceutical companies through proprietary platforms (Sagan Agents, Ferma, Patient Scribe) that combine conversational AI with proprietary HCP/patient panels spanning 60,000+ healthcare professionals and 700M+ benchmark datapoints. The firm provides tracking studies (promotional, brand, chart audits, media, HCP-patient conversations) and strategic consulting (launch excellence, commercial analytics, competitive intelligence) covering the full drug lifecycle.
Product overview
ZoomRx is a strategic life sciences consulting firm offering an integrated platform-plus-modules architecture. The core offering combines proprietary AI technology (Sagan Agents platform) with deep therapeutic expertise and proprietary data assets (60K+ HCP panel, 700M+ benchmark datapoints). The main products include: Sagan Agents (continuous intelligence platform with Strategic Insights Agents, Data Archive Intelligence, and Agentic Market Research modules); Ferma (AI market intelligence with Ferma Congress and Ferma Agents); Patient Scribe (conversational chart audit platform); and Sagan (conversational survey platform). Supporting services include Promotional Effectiveness Tracking (PET), Brand Tracking (ATU), Patient Chart Audits (PCA), Media Tracking, HCP-Patient Conversations, Launch Excellence consulting, and Commercial Consulting Analytics. The portfolio integrates primary research with secondary data to deliver AI-powered pharma insights across the drug lifecycle.
Differentiator
Problem solved
Functional benefit
Brands
- Sagan Agents: AI-powered continuous intelligence platform for life sciences that converts siloed data into an always-on operating system
- Sagan
- Ferma
- Ferma Congress
- Patient Scribe
- Curie
Companies that use ZoomRx
Customer profileNamed customers19 records
Segments4 records
Ideal customer profiles1 record
ZoomRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability10 records
Feature6 records
ZoomRx partnerships and signals
Strategic signalScale indicators8 records
Recent moves5 records
Expansion highlights5 records
ZoomRx competitors and assessment
Company assessmentBroad incumbents
- ZS Associates: ZS Associates is a large management consulting and technology firm specializing in pharma and healthcare, with deep capabilities in commercial analytics, AI-driven sales force effectiveness, and market research. It overlaps with ZoomRx but serves a much broader portfolio of pharma services.
Direct peers
- IQVIA: IQVIA is the largest global provider of pharma market research, commercial analytics, and real-world evidence. It directly competes with ZoomRx in pharma insights, brand tracking, and commercial strategy, with significantly broader data assets and enterprise reach.
- Definitive Healthcare: Definitive Healthcare is a healthcare commercial intelligence platform serving pharma and biotech with provider data, claims analytics, and market insights. It competes with ZoomRx in commercial intelligence and HCP/patient data layers serving pharma commercial teams.
- Informa Pharma Intelligence (Citeline): Citeline (formerly Pharma Intelligence, part of Informa) provides pharma pipeline intelligence, clinical trial analytics, and commercial insights. It directly competes with ZoomRx's Ferma platform for drug pipeline and competitive intelligence workflows.
- Ipsos Healthcare: Ipsos Healthcare is the global pharma and healthcare research arm of Ipsos, offering market research, brand tracking, and HCP/patient insights. It is a direct peer for ZoomRx's market research and tracking-study business lines.
- GlobalData: GlobalData provides pharma market research, competitive intelligence, and industry analytics to biopharma. It competes with ZoomRx's market and competitive intelligence solutions, particularly in drug pipeline tracking and therapy-area insights.
- EVERSANA: EVERSANA is a commercial pharma services provider covering market access, patient services, and commercial analytics. It overlaps with ZoomRx in commercial strategy, market access, and life sciences insights for global biopharma clients.
- Trinity Life Sciences: Trinity Life Sciences is a life sciences strategy consulting and market research firm offering commercial analytics, brand tracking, and competitive intelligence to global pharma. It is one of ZoomRx's closest direct peers in the strategic consulting + insights hybrid model.
- Kantar (Health division): Kantar's Health division delivers market research and insights for pharma and consumer health, including brand tracking and HCP research. It is a direct peer for ZoomRx's brand tracking (ATU), promotional effectiveness, and HCP research offerings.
- Clarivate: Clarivate provides pharma intelligence, drug pipeline data, and commercial analytics (formerly Thomson Reuters Pharma). It directly competes with ZoomRx's Ferma platform for drug pipeline, competitive intelligence, and biopharma commercial decision support.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
ZoomRx social profiles
Digital presenceZoomRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
ZoomRx leadership team
Management profileNumber of profiles
Profiles1 record
ZoomRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ZoomRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ZoomRx
What does ZoomRx do?
ZoomRx delivers AI-powered market research and life sciences consulting to pharmaceutical companies through proprietary platforms (Sagan Agents, Ferma, Patient Scribe) that combine conversational AI with proprietary HCP/patient panels spanning 60,000+ healthcare professionals and 700M+ benchmark datapoints. The firm provides tracking studies (promotional, brand, chart audits, media, HCP-patient conversations) and strategic consulting (launch excellence, commercial analytics, competitive intelligence) covering the full drug lifecycle.
Is ZoomRx a public or private company?
ZoomRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ZoomRx founded?
ZoomRx was founded in 2010. It employs 251 to 500 people.
Where is ZoomRx based?
ZoomRx is headquartered in Chennai, India, in the Asia region.
How does ZoomRx make money?
Three revenue lines are on record. Life Sciences Consulting is the primary driver. The others are sagan Agents Platform Subscription and market Research Tracking Studies.
Who are ZoomRx's main competitors?
ZS Associates is listed as a broad incumbent. Direct peers are IQVIA, Definitive Healthcare, Informa Pharma Intelligence (Citeline), Ipsos Healthcare, GlobalData, EVERSANA, Trinity Life Sciences, Kantar (Health division) and Clarivate.
Does ZoomRx have an API?
Yes. Sagan Agents supports bring-your-own API key (BYOK) deployment, suggesting an API exists for client integration. The platform mentions SSO integration, role-based access controls, and audit logging. Specific API documentation URL was not provided in the source material.